30,296 Shares in Encompass Health Co. (NYSE:EHC) Acquired by International Assets Investment Management LLC

International Assets Investment Management LLC purchased a new position in shares of Encompass Health Co. (NYSE:EHC) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 30,296 shares of the company’s stock, valued at approximately $20,210,000.

A number of other hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. raised its position in Encompass Health by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 9,546,953 shares of the company’s stock worth $641,173,000 after purchasing an additional 31,380 shares during the period. William Blair Investment Management LLC lifted its stake in shares of Encompass Health by 6.4% in the 3rd quarter. William Blair Investment Management LLC now owns 5,676,379 shares of the company’s stock valued at $381,226,000 after acquiring an additional 342,512 shares during the last quarter. Invesco Ltd. boosted its holdings in Encompass Health by 22.3% during the 3rd quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock valued at $266,914,000 after acquiring an additional 724,544 shares during the period. FMR LLC grew its position in Encompass Health by 11.6% during the 3rd quarter. FMR LLC now owns 1,374,755 shares of the company’s stock worth $92,329,000 after acquiring an additional 142,633 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its stake in Encompass Health by 5.3% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,288,858 shares of the company’s stock worth $86,560,000 after purchasing an additional 64,442 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $83.21 on Friday. The business has a fifty day simple moving average of $79.15 and a two-hundred day simple moving average of $71.55. The firm has a market capitalization of $8.33 billion, a P/E ratio of 22.49, a P/E/G ratio of 1.30 and a beta of 0.92. The company has a current ratio of 1.37, a quick ratio of 1.28 and a debt-to-equity ratio of 1.14. Encompass Health Co. has a 12 month low of $57.55 and a 12 month high of $85.84.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The business had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same quarter in the prior year, the company earned $0.88 earnings per share. The business’s revenue was up 13.4% compared to the same quarter last year. On average, equities analysts forecast that Encompass Health Co. will post 4.1 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.72%. The ex-dividend date of this dividend is Friday, June 28th. Encompass Health’s dividend payout ratio (DPR) is 16.22%.

Insider Transactions at Encompass Health

In other news, CEO Mark J. Tarr sold 44,976 shares of Encompass Health stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $83.27, for a total value of $3,745,151.52. Following the completion of the transaction, the chief executive officer now owns 554,098 shares of the company’s stock, valued at approximately $46,139,740.46. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 2.10% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on EHC. Stephens reaffirmed an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a research note on Tuesday, January 16th. Truist Financial raised their target price on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Mizuho increased their price objective on Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $83.00 price target on shares of Encompass Health in a research note on Friday, February 9th. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average target price of $90.29.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.